AviadoBio
PrivateLast Round
Grant
Mar 31, 2026
Total Funding Raised
$151.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AviadoBio is a biotechnology company that develops innovative gene therapies aimed at transforming the lives of individuals affected by severe neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AviadoBio Comparables
Compare AviadoBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coave Therapeutics | 84% | |
| Capsida Biotherapeutics | 81% | |
| DegenRx B.V. | 79% | |
AviadoBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 31, 2026 | ||||
| Strategic | Oct 8, 2024 | ||||
| Series A | Dec 2, 2021 | ||||
| Seed | Apr 1, 2021 | ||||
| Seed | Dec 1, 2020 |
Key People
Founding team and executive leadership
AviadoBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Association for Frontotemporal Degeneration | Grant |
| EQT Life Sciences | Series A |
| SV Health Investors | Seed, Series A |
| New Enterprise Associates (NEA) | Series A |
| F-Prime Capital | Seed, Series A |
| Advent Life Sciences | Seed, Series A |
| Monograph Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Combining RNAi platform with TfR1 capsid for CNS gene silencing.
- Apr 27, 2026
Presenting drug candidate data at the ASGCT Annual Meeting.
AviadoBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AviadoBio's valuation, stock price, and market status.